Bardy Diagnostics, maker of cardiac-monitoring adhesive patches, announced yesterday that Kevin Hykes began serving as the company's president and CEO on August 31. Hykes was formerly the president and CEO of Relievant Medical Systems, Metaventon and Cameron Health. Earlier in his career he spent 16 years at Medtronic. As Bardy Diagnostics' new head, he'll help develop and execute the company's business strategy while keeping an eye on its overall operations.
As a result, Dr. Gust H. Bardy, the company's founder and prior head, has shifted into roles as the company's chief medical officer and chief innovation officer. He retains his position as chairman of the board.
"I'm very excited and pleased to have Kevin join our executive team as president and CEO," Bardy said in a statement. "I've had the privilege of working with Kevin when he was CEO of the last company I founded, Cameron Health, where he led the global commercialization of the subcutaneous implantable cardioverter defibrillator and ultimately our successful sale to Boston Scientific.
"I am looking forward to transitioning into my new role as chief medical officer and chief innovation officer and turning day-to-day management of the company over to Kevin as we continue to experience tremendous growth in the adoption of our CAM p-wave centric patch as the new standard of care in ambulatory cardiac monitoring devices," he said.
Catapult Health has promoted Julie Dimoulakis into the roles of president and COO, the virtual preventive and primary care company announced today. She originally joined Catapult in 2011, and over the course of her tenure has used her experience with worksite wellness programs to help build the company's platform. Previously she held roles at Viverae, Park Nicollet and Health Fitness Corporation.
"With the release of our VirtualCheckup this month, we are leveraging our telehealth expertise to bring preventive care to people anytime, anywhere – at work, at home, or on vacation – while maintaining the clinical depth of an office-based annual exam," David Michel, CEO and chairman of Catapult Health, said in a statement. "Julie's leadership skills, her passion for empowering others, and her unwavering commitment to always 'doing what's right' make her the perfect choice to lead Catapult as we transform the delivery of preventive and primary care in America."
Chronic disease management platform Welldoc has announced three new hires to its executive team.
The first is Keith Reynolds as COO, who was previously the VP of enterprise health plans and market strategy at CVS Health, as well as the CCO of Castlight. He's followed by new chief revenue officer David Driscoll, who recently served a similar role at Streamline Health, and SVP of sales Linda Piazza, formerly a national sales executive at Kaiser Permanente.
"The specialized experiences that Keith, Dave and Linda bring to our commercial team will be key to our success,” Kevin McRaith, CEO at Welldoc, said in a statement. “Together they bring more than 60 years of leadership in commercializing digital health platforms, payer sales management and business development in the chronic disease space. We are delighted to welcome them to Welldoc and look forward to improving the lives of those living with chronic diseases.”
With the international market in its sights, Headspace has announced a new chief international officer role for its business that will be filled by London-based Jolawn Victor. A veteran of Intuit Quickbooks, PepsiCo, Kraft and General Mills, she will report to the company's president and COO as she works to guide Headspace's localized consumer products, partnerships and enterprise business development outside of the U.S.
"I am thrilled to join Headspace and to be able to help increase the awareness of mental health and wellness in existing and emerging markets," Victor said in a statement, "especially today, when a variety of pressing challenges undoubtedly impact[s] our ability to feel safe and live healthy lives in nearly every country around the world."
After two years with the unit, Uber Health lead Dan Trigub is leaving the company to start his own healthcare venture, STAT News reports. Trigub told media that he will be cofounding a New York City-based, early-stage company that's still in stealth. To do so, the venture has partnered with Redesign Health.